165 related articles for article (PubMed ID: 27733172)
21. Oligosaccharide G19 inhibits U-87 MG human glioma cells growth in vitro and in vivo by targeting epidermal growth factor (EGF) and activating p53/p21 signaling.
Liu H; Zhou L; Shi S; Wang Y; Ni X; Xiao F; Wang S; Li P; Ding K
Glycobiology; 2014 Aug; 24(8):748-65. PubMed ID: 24799378
[TBL] [Abstract][Full Text] [Related]
22. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.
Miyake T; Pradeep S; Wu SY; Rupaimoole R; Zand B; Wen Y; Gharpure KM; Nagaraja AS; Hu W; Cho MS; Dalton HJ; Previs RA; Taylor ML; Hisamatsu T; Kang Y; Liu T; Shacham S; McCauley D; Hawke DH; Wiktorowicz JE; Coleman RL; Sood AK
Clin Cancer Res; 2015 Jul; 21(14):3286-97. PubMed ID: 25878333
[TBL] [Abstract][Full Text] [Related]
23. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
24. Oridonin inhibits tumor growth in glioma by inducing cell cycle arrest and apoptosis.
Zhang XH; Liu YX; Jia M; Han JS; Zhao M; Ji SP; Li AM
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):29-36. PubMed ID: 25553351
[TBL] [Abstract][Full Text] [Related]
25. Targeting the nuclear transport machinery by rational drug design.
Mao L; Yang Y
Curr Pharm Des; 2013; 19(12):2318-25. PubMed ID: 23082981
[TBL] [Abstract][Full Text] [Related]
26. XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor.
Pan L; Cheng C; Duan P; Chen K; Wu Y; Wu Z
J Exp Clin Cancer Res; 2021 Aug; 40(1):255. PubMed ID: 34384466
[TBL] [Abstract][Full Text] [Related]
27. Identifying drug-target selectivity of small-molecule CRM1/XPO1 inhibitors by CRISPR/Cas9 genome editing.
Neggers JE; Vercruysse T; Jacquemyn M; Vanstreels E; Baloglu E; Shacham S; Crochiere M; Landesman Y; Daelemans D
Chem Biol; 2015 Jan; 22(1):107-16. PubMed ID: 25579209
[TBL] [Abstract][Full Text] [Related]
28. Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.
Renner G; Janouskova H; Noulet F; Koenig V; Guerin E; Bär S; Nuesch J; Rechenmacher F; Neubauer S; Kessler H; Blandin AF; Choulier L; Etienne-Selloum N; Lehmann M; Lelong-Rebel I; Martin S; Dontenwill M
Cell Death Differ; 2016 Apr; 23(4):640-53. PubMed ID: 26470725
[TBL] [Abstract][Full Text] [Related]
29. Discovery and biological evaluation of a small-molecule inhibitor of CRM1 that suppresses the growth of triple-negative breast cancer cells.
Gao J; Chu P; Liu C; Sun Z; Liu Q; Yang Y
Traffic; 2021 Jul; 22(7):221-229. PubMed ID: 34021516
[TBL] [Abstract][Full Text] [Related]
30. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
31. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
[TBL] [Abstract][Full Text] [Related]
32. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma.
Liu E; Wu J; Cao W; Zhang J; Liu W; Jiang X; Zhang X
J Neurooncol; 2007 Dec; 85(3):263-70. PubMed ID: 17594054
[TBL] [Abstract][Full Text] [Related]
33. Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.
Yeo CW; Ng FS; Chai C; Tan JM; Koh GR; Chong YK; Koh LW; Foong CS; Sandanaraj E; Holbrook JD; Ang BT; Takahashi R; Tang C; Lim KL
Cancer Res; 2012 May; 72(10):2543-53. PubMed ID: 22431710
[TBL] [Abstract][Full Text] [Related]
34. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
36. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.
Ma W; Na M; Tang C; Wang H; Lin Z
Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142
[TBL] [Abstract][Full Text] [Related]
38. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
[TBL] [Abstract][Full Text] [Related]
39. Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest.
Liu B; Gao YQ; Wang XM; Wang YC; Fu LQ
Mol Med Rep; 2014 Aug; 10(2):1046-50. PubMed ID: 24889088
[TBL] [Abstract][Full Text] [Related]
40. CRM1-dependent p53 nuclear accumulation in lung lesions of a bitransgenic mouse lung tumor model.
Chen L; Moore JE; Samathanam C; Shao C; Cobos E; Miller MS; Gao W
Oncol Rep; 2011 Jul; 26(1):223-8. PubMed ID: 21519798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
